Literature DB >> 1973993

Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia.

Y Giovangrandi, F Daffos, C Kaplan, F Forestier, J Mac Aleese, M Moirot.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 1973993     DOI： 10.1016/0140-6736(90)91842-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.

Authors:  Günther Giers; Folker Wenzel; Markus Stockschläder; Regina Riethmacher; Horst Lorenz; Boris Tutschek
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

2.  High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1).

Authors:  Huiying Zhi; Maria Therese Ahlen; Aye Myat Myat Thinn; Hartmut Weiler; Brian R Curtis; Bjørn Skogen; Jieqing Zhu; Peter J Newman
Journal:  Blood Adv       Date:  2018-11-13

Review 3.  Intrauterine transfusion with red cells and platelets.

Authors:  K J Moise
Journal:  West J Med       Date:  1993-09

4.  CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes.

Authors:  Nanyan Zhang; Huiying Zhi; Brian R Curtis; Sridhar Rao; Chintan Jobaliya; Mortimer Poncz; Deborah L French; Peter J Newman
Journal:  Blood       Date:  2015-12-03       Impact factor: 22.113

5.  Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.

Authors:  Cedric Ghevaert; David A Wilcox; Juan Fang; Kathryn L Armour; Mike R Clark; Willem H Ouwehand; Lorna M Williamson
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

6.  Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.

Authors:  Tamam Bakchoul; Andreas Greinacher; Ulrich J Sachs; Annika Krautwurst; Harald Renz; Habi Harb; Gregor Bein; Peter J Newman; Sentot Santoso
Journal:  Blood       Date:  2013-05-03       Impact factor: 22.113

7.  Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia.

Authors:  Huiying Zhi; Maria T Ahlen; Björn Skogen; Debra K Newman; Peter J Newman
Journal:  Blood Adv       Date:  2021-09-28

Review 8.  Foetal and neonatal alloimmune thrombocytopaenia.

Authors:  Cecile Kaplan
Journal:  Orphanet J Rare Dis       Date:  2006-10-10       Impact factor: 4.123

9.  Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia.

Authors:  Brian Vadasz; Pingguo Chen; Issaka Yougbaré; Darko Zdravic; June Li; Conglei Li; Naadiya Carrim; Heyu Ni
Journal:  Genes Dis       Date:  2015-06-01

10.  Risk factors for severity of thrombocytopenia in full term infants: a single center study.

Authors:  Amira M Saber; Shereen P Aziz; Al Zahraa E Almasry; Ramadan A Mahmoud
Journal:  Ital J Pediatr       Date:  2021-01-12       Impact factor: 2.638
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.